GlassScriptPhysician profile
John Vann Parker
NPI 1225075955
$1,996.69
in general payments reported to CMS, 2019-2025
28 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $120 · 2021: $613 · 2022: $280 · 2023: $248 · 2024: $295 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $667.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $386.95 | 2020-2023 | |
| Astellas Pharma US INC | $258.64 | 2023-2025 | Veozah |
| Davol INC. | $201.31 | 2019 | |
| Aspira Women'S Health INC | $174.99 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $162.67 | 2019-2024 | Gardasil 9, Gardasil |
| Mayne Pharma Commercial LLC | $124.37 | 2021-2025 | |
| Daiichi Sankyo INC. | $67.06 | 2019-2022 | |
| Hologic Sales and Service, LLC | $63.95 | 2019-2025 | Aptima |
| Organon LLC | $62.45 | 2021-2025 | Nexplanon |
| Evofem Biosciences, INC. | $59.37 | 2021-2022 | |
| Exeltis, USA INC. | $57.14 | 2021 | |
| Exact Sciences Corporation | $44.47 | 2023-2025 | Cologuard Collection Kit |
| Gynesonics, INC. | $38.70 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Smith+Nephew, INC. | $35.45 | 2024 | Grafix Pl, Stravix |
| Coopersurgical, INC. | $30.99 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $27.49 | 2019 | |
| Sage Therapeutics, LLC | $24.53 | 2023 | |
| Avion Pharmaceuticals | $23.79 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $20.86 | 2021 | |
| Shield Therapeutics INC | $19.76 | 2023 | Accrufer |
| Pfizer INC. | $19.73 | 2022 | |
| Myovant Sciences INC. | $19.35 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.22 | 2019 | |
| Currax Pharmaceuticals LLC | $15.04 | 2022 | |
| Therapeuticsmd, INC. | $14.87 | 2020 | |
| Minerva Surgical, INC | $14.28 | 2025 | |
| Agile Therapeutics, INC. | $13.26 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Parker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.